Navigate today’s most pressing health industry challenges with a leading global expert by your side.
Discover intelligent digital solutions to help improve outcomes, manage costs, and solve the toughest healthcare challenges.
Meet growing needs for innovative insurance solutions while increasing operational health and improving compliance.
Financial modeling & industrialization
Insurance risk assessment
Retirement & Benefits
Deliver on the promises of the past and create smart solutions for the future.
Compensations & benefits
Benefit plan evaluation
Manage complex risks using data-driven insights, advanced approaches, and deep industry experience.
Auto policy underwriting
Software performance enhancement
Mortgage platform for investments & reinsurance
Solvency II reporting & compliance
This is a place where your ideas and insights make an impact. Where an independent, entrepreneurial spirit is an advantage. And where diversity of thought and experience makes us who we are.
Data-driven insight. Deep expertise. Transformative innovation. Since 1947, Milliman has delivered intelligent solutions to improve health and financial security.
Medicare Supplement insurance (also referred to as MedSupp or Medigap) provides coverage for a beneficiary’s various obligations under traditional Medicare Fee for Service (Medicare FFS), such as the deductible and coinsurance for Parts A and B.
A brief summary of MedSupp regulation, benefits, and rating includes the following:
The growth of the Medicare-eligible market will keep the MedSupp industry viable and relevant. MedSupp membership grew approximately 4% from 2017 to 2018, to approximately 14 million members.1 Competitive loss ratios and average premiums vary by state, with overall 2018 industry loss ratios running below 80% and average premiums equal to about $200 per member per month (PMPM). Market/competitive concentration also varies by state, with several carriers involved in the MedSupp market at varying levels of market concentration and geographic distribution.
The MedSupp market has its own regulatory changes and challenges. The Medicare Access and CHIP Reauthorization Act of 2015 (“MACRA”) will affect the MedSupp industry in calendar year 2020 due to the introduction of new benefit coverage restrictions affecting what can and cannot be covered, depending on when an individual turns age 65 or otherwise qualifies for Medicare for the first time.
At Milliman, we have the experience, resources, and industry knowledge to help carriers evaluate the ramifications of the new legislation and stay ahead of emerging legislation and market trends. We specialize in the development and maintenance of MedSupp blocks of business.
We have extensive depth and deep connectivity in the MedSupp industry, providing independent third party strategic and tactical expertise and assistance across a spectrum of needs for both new potential market entrants and longstanding legacy carriers:
We’re here to help you break through complex challenges and achieve next-level success.